Bristol Myers Squibb BMY
NYSE BMY
$61.60 -1.40 (-2.21%)
As of: Oct 23, 2026 · 2:20 PM EDT

Bristol Myers Squibb (BMY) Change in Accured Expenses (2021 - 2026)

Updated

Bristol Myers Squibb (BMY) recorded Change in Accured Expenses of $360 million in Q2 2026, down 59.1% from $881 million a year earlier.

Analysis

Bristol Myers Squibb (BMY) Change in Accured Expenses (2021 - 2026) Analysis & Trends

On a TTM basis, Bristol Myers Squibb's Change in Accured Expenses came in at -$3.83 billion as of Jun 30, 2026; for FY2025, it came in at -$441 million.

  • Across earlier years, Change in Accured Expenses came in at $1.48 billion in FY2024 (+64.2%), $904 million in FY2023 (+111.7%), $427 million in FY2022 (-50.5%) and $863 million in FY2021 (-27.4%).
  • Quarterly Change in Accured Expenses has ranged from -$3.5 billion in Q1 2026 to $1.82 billion in Q3 2024 over the past five years.
  • On a year-over-year basis, Change in Accured Expenses rose in two of the last four quarters, with an average decline of 6.7%.
  • Peak year-over-year performance for Change in Accured Expenses in the last five years was growth of 141.9% in Q2 2022, against a decline of 59.1% in Q2 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at -$3.5 billion (Q1 2026), -$2.4 billion (Q4 2025) and $1.7 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accured Exp. (Qtr)
1 Eli Lilly 1,129.53 Bn 1,098.12 Bn 19.71 Bn -
2 Johnson & Johnson 634.39 Bn 554.25 Bn 17.30 Bn 2.41 Bn
3 AbbVie 505.42 Bn 478.53 Bn 12.70 Bn 1.20 Bn
4 Merck 358.13 Bn 312.50 Bn 12.21 Bn -
5 Novartis Ag 289.84 Bn 253.83 Bn 11.24 Bn -
6 Astrazeneca 265.39 Bn 239.08 Bn 12.86 Bn -
7 Amgen 238.10 Bn 193.50 Bn 7.24 Bn 901.00 Mn
8 Gilead Sciences 194.55 Bn 168.75 Bn 6.22 Bn 338.00 Mn
9 Pfizer 171.08 Bn 117.73 Bn 10.94 Bn -
10 Bristol Myers Squibb 125.80 Bn 77.07 Bn 9.25 Bn 360.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 360.00 Mn
Mar 31, 2026 -3.50 Bn
Dec 31, 2025 -2.40 Bn
Sep 30, 2025 1.70 Bn
Jun 30, 2025 881.00 Mn
Mar 31, 2025 -627.00 Mn
Dec 31, 2024 -405.00 Mn
Sep 30, 2024 1.82 Bn
Jun 30, 2024 735.00 Mn
Mar 31, 2024 -665.00 Mn
Dec 31, 2023 -211.00 Mn
Sep 30, 2023 1.53 Bn
Jun 30, 2023 492.00 Mn
Mar 31, 2023 -910.00 Mn
Dec 31, 2022 -303.00 Mn
Sep 30, 2022 1.14 Bn
Jun 30, 2022 520.00 Mn
Mar 31, 2022 -930.00 Mn
Dec 31, 2021 -39.00 Mn
Sep 30, 2021 908.00 Mn
API Access

Bristol Myers Squibb Change in Accured Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=BMY&period=max&api_key=YOUR_API_KEY